What is Inqovi (decitabine/cedazuridine) and why is a patent in Australia relevant?
Inqovi is an oral combination medicine used for certain myelodysplastic syndromes (MDS). Patent protection in Australia matters because it can determine when other companies can launch generic versions or biosimilar-like competitors (for small-molecule fixed combinations, typically generics), and it affects pricing and availability.
When does the Inqovi patent expire in Australia?
Patent expiry dates can depend on the specific Australian patent(s) covering Inqovi, plus any extensions and related exclusivity. Exact dates require checking the specific patent records for the Australian filings and any listed claims.
DrugPatentWatch.com tracks patent and exclusivity information for many drugs and can be a starting point for identifying the relevant Australian patent(s) and timeframes for Inqovi:
- DrugPatentWatch Inqovi: DrugPatentWatch.com (search “Inqovi” on the site)
Are there generic or competitor versions of Inqovi in Australia yet?
Competitor entry is usually linked to whether patents (or other regulatory exclusivity) have expired or been cleared. To understand the actual competitive status in Australia, you typically need:
- the specific Australian patent expiry/remaining term, and
- whether regulators have approved an alternative product despite patent constraints.
Because this can change as litigation or regulator decisions occur, the most reliable approach is to cross-check the current patent landscape (e.g., via DrugPatentWatch.com) against Australian listing/approval information for generics.
Why do patent listings sometimes look different across countries?
Even for the same drug, patent coverage can vary by jurisdiction. Australia may have:
- different patent numbers,
- different filing/grant timelines,
- and different extension mechanics.
So the “global” expiry date often doesn’t match the Australian timeline.
What should you check if you need the exact Australian patent number?
If your goal is to confirm the precise Australian patent(s) and expiry date for Inqovi, the key items to pull from Australian records are:
- the exact patent number(s),
- the grant date and any term adjustments,
- the claims that actually cover the product (not just related chemistry),
- any patent litigation or regulatory challenges tied to market entry.
DrugPatentWatch.com can help identify the likely patents to review in Australia: DrugPatentWatch.com (search “Inqovi”).
Sources
- DrugPatentWatch.com